18 November 2023
: Case report
Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series
Unusual or unexpected effect of treatment
John P. Palmer1ADEF*, Arief A. Suriawinata2BDE, Shaofeng Yan2BDE, Darcy A. Kerr2BDE, Muhammad Z. Afzal1ABCE, Keisuke Shirai1ADEFDOI: 10.12659/AJCR.938537
Am J Case Rep 2023; 24:e938537
Figure 3. Case 1: Patient’s primary melanoma (A–C) and metastatic melanoma (D, E). Hematoxylin and eosin stain of primary melanoma from mid back (A, 5×). Tumor cells show nuclear atypia with mitotic activity (B, 200×) and positive immunostain for SOX10 (C, 200×). Needle core biopsy of the left axilla lymph node shows metastatic melanoma associated with lymphoid tissue (D, 20× and E, 200×).






